HER2-Low Status Is Not Accurate in Breast Cancer Core Needle Biopsy Samples: An Analysis of 5610 Consecutive Patients.

Yujie LuSiji ZhuYiwei TongXiaochun FeiWu JiangKunwei ShenXiaosong Chen

Published in: Cancers (2022)

A relatively low concordance rate was found when evaluating HER2-Low status between CNB and SES samples in HER2-Negative breast cancer patients, indicating the necessity of retesting HER2 low status at surgery, which may guide further therapy in the era of anti-HER2 ADCs.

Keyphrases

end stage renal disease
chronic kidney disease
minimally invasive
ultrasound guided
stem cells
peritoneal dialysis
high resolution
acute coronary syndrome
prognostic factors
mesenchymal stem cells